Jiangsu Hengrui Medicine Co., Ltd. Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd.

600276

Rang in Aktien #543
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
Aktienkurs
$6.89
Marktkapitalisierung
$43.94B
Veränderung (1 Tag)
-2.91%
Veränderung (1 Jahr)
-24.78%
Land
CN
Handel Jiangsu Hengrui Medicine Co., Ltd. (600276)

Kategorie

Healthcare
Dividendenrendite-Verlauf für Jiangsu Hengrui Medicine Co., Ltd. (600276)
Dividendenrendite (TTM) von Jiangsu Hengrui Medicine Co., Ltd. (Aktienkürzel: 600276) zum 2024-12-31: 0.44%
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.37%
Dividendenrendite-Verlauf für Jiangsu Hengrui Medicine Co., Ltd. (600276) von 2001 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
2026 (TTM) 0.43% 30.30%
2025 0.33% -25.00%
2024 0.44% 22.22%
2023 0.36% -12.20%
2022 0.41% 24.24%
2021 0.33% 94.12%
2020 0.17% -19.05%
2019 0.21% 10.53%
2018 0.19% -5.00%
2017 0.20% -9.09%
2016 0.22% 15.79%
2015 0.19% -38.71%
2014 0.31% 10.71%
2013 0.28% -28.21%
2012 0.39% 18.18%
2011 0.33% 65.00%
2010 0.20% -13.04%
2009 0.23% -28.13%
2008 0.32% -3.03%
2007 0.33% -61.18%
2006 0.85% -82.18%
2005 4.77% 19.55%
2004 3.99% 1.53%
2003 3.93% 37.89%
2002 2.85% -24.60%
2001 3.78% 0.00%
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber